AVEO Oncology
AVEO
#7494
Rank
$0.52 B
Marketcap
$15.00
Share price
0.00%
Change (1 day)
170.76%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -$29.04 Million USD

According to AVEO Oncology 's latest financial reports the company's current earnings are $94.31 Million USD. In 2021 the company made an earning of -$53.35 Million USD a decrease over its 2020 earnings that were of -$35.59 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -$29.04 Million-45.56%
2021 -$53.35 Million49.9%
2020 -$35.59 Million-479.04%
2019 $9.38 M-276.17%
2018 -$5.33 Million-91.79%
2017 -$64.93 Million142.38%
2016 -$26.79 Million78.51%
2015 -$15.01 Million-71.55%
2014 -$52.74 Million-50.72%
2013 -$0.11 Billion-4.88%
2012 -$0.12 Billion-426.29%
2011 $34.48 M-159.85%
2010 -$57.63 Million35.33%
2009 -$42.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
$33.59 B-115,791.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$10.28 B-35,524.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$1.01 B-3,582.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$5.16 B-17,889.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$11.91 B-41,113.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-$2.26 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA